MedCity News

MedCityNews is a top online platform that covers the business side of healthcare innovation. We provide valuable insights into upcoming trends and important topics through a combination of breaking news and in-depth analysis. Our content focuses on both emerging startups and well-known industry figures, as well as key policies and significant deals in the healthcare sector.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#427248

United States

#184754

Health/Health

#3559

Traffic sources

Monthly visitors

Articles

Beyond Technology: Aligning AI Tools with Systemic Change in Healthcare

1 day ago | medcitynews.com | Travis Bias

Two years ago, every health conference I attended had multiple panels on clinician burnout. The problem is well known, and the actual system-level contributors have been called out. In the last year, the solution to burnout is splashed on every conference app log-in screen: generative artificial intelligence (AI).
Gilead Sciences Lands First FDA Approval of a Twice-a-Year HIV PrEP Drug

1 week ago | medcitynews.com | Frank Vinluan

A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a twice-yearly injection. The regulatory decision announced Wednesday covers use of the antiviral drug, lenacapavir, for HIV-1 pre-exposure prophylaxis (PrEP). The approval is for adults and adolescents weighing at least 35 kg (about 77.1 pounds) who are at risk of sexually acquired HIV-1.
Are You a Startup Seeking to Redefine Healthcare Operations with AI? Apply to Pitch Perfect at INVEST Digital Health

1 week ago | medcitynews.com | Stephanie Baum

Are you developing health tech solutions with AI? We’re looking for the next wave of digital health startups using artificial intelligence to transform the day-to-day work of providers. If your solution streamlines diagnosis, clinical documentation, scheduling, or patient engagement, we’d welcome your application to Pitch Perfect at INVEST Digital Health. The conference is scheduled for September 18 in Dallas, Texas at Pegasus Park, in collaboration with Health Wildcatters. To apply, click here.
FDA Pilot Program Shortens Drug Reviews; ‘We Have Got to Modernize the Agency,’ Makary Says at BIO

1 week ago | medcitynews.com | Frank Vinluan

The FDA is implementing a new pilot program that could incentivize development of certain new drugs by dramatically shortening their regulatory reviews. But to qualify, a drug must address specified national health interests. The FDA already has a program that speeds up regulatory review of rare disease drugs. This priority review voucher program (PRV) was created by Congress, initially for rare and neglected diseases, then later expanded to include rare pediatric diseases.
Rising Healthcare Costs: What Employers Are Doing to Manage Expenses, Per Mercer

1 week ago | medcitynews.com | Marissa Plescia

Employers are already struggling with rising healthcare costs in 2025, and early signs suggest these challenges will persist — potentially worsening in 2026, according to Tracy Watts, senior partner at consulting firm Mercer. And it’s getting to a point where employers may have to start shifting costs to employees, she added.
Sarepta Stops Stop Shipments of Muscular Dystrophy Gene Therapy After Second Patient Death

1 week ago | medcitynews.com | Frank Vinluan

A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy — the second fatality reported by the company in the past three months. Like the first patient, the latest death followed a case of acute liver failure. Along with disclosing the latest patient death on Sunday, Sarepta said it is developing new safety measures to mitigate the liver injury risk to patients treated with the gene therapy, Elevidys.
INVEST Pitch Perfect Spotlight: How DUOS Is Leveraging Tech To Support Older Adults

1 week ago | medcitynews.com | Marissa Plescia

The number of Americans ages 65 and older is expected to increase to 82 million by 2050, a 47% increase from 58 million in 2022. And accessing quality healthcare is often confusing and a significant challenge for this population. That’s what DUOS, a technology-enabled service provider for Medicare Advantage plans, hopes to change. It supports older adults and their caregivers by addressing health-related social needs and connecting patients to care.
ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More

1 week ago | medcitynews.com | Frank Vinluan

Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to their pipelines. One of the most talked about drugs at this year’s annual meeting of the American Society of Clinical Oncology was a bispecific antibody that did not even have data presented at the conference. Summit Therapeutics announced preliminary Phase 3 data for ivonescimab, which is designed to target the proteins EGFR and VEGF.
Blue Shield of California, Zocdoc Partner To Help Members Schedule Care

2 weeks ago | medcitynews.com | Marissa Plescia

Scheduling appointments can be a significant challenge for patients, often forcing them to navigate multiple portals, download a new app or deal with outdated directories. That’s why Blue Shield of California, a nonprofit health plan with 6 million members, announced Wednesday that it is teaming up with New York City-based Zocdoc, an online marketplace that helps patients find and book appointments with in-network providers.
AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact

2 weeks ago | medcitynews.com | Frank Vinluan

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R&D agreement announced Friday does not specify any targets or indications. But AstraZeneca said the alliance includes a preclinical small molecule oral drug for immunological diseases.